IL326152A - Solid state forms of gusacitinib - Google Patents
Solid state forms of gusacitinibInfo
- Publication number
- IL326152A IL326152A IL326152A IL32615226A IL326152A IL 326152 A IL326152 A IL 326152A IL 326152 A IL326152 A IL 326152A IL 32615226 A IL32615226 A IL 32615226A IL 326152 A IL326152 A IL 326152A
- Authority
- IL
- Israel
- Prior art keywords
- gusacitinib
- solid state
- state forms
- forms
- solid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2023/109559 WO2025020171A1 (en) | 2023-07-27 | 2023-07-27 | Crystalline forms of a jak/syk inhibitor |
| PCT/US2024/039745 WO2025024764A1 (en) | 2023-07-27 | 2024-07-26 | Solid state forms of gusacitinib |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL326152A true IL326152A (en) | 2026-03-01 |
Family
ID=92626913
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL326152A IL326152A (en) | 2023-07-27 | 2024-07-26 | Solid state forms of gusacitinib |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2024301493A1 (en) |
| IL (1) | IL326152A (en) |
| WO (2) | WO2025020171A1 (en) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2969977T3 (en) | 2011-08-23 | 2024-05-23 | Libertas Bio Inc | Pyrimido-pyridazinone compounds and use thereof |
| AR106830A1 (en) * | 2015-12-04 | 2018-02-21 | Asana Biosciences Llc | USES OF PIRIDAZINONES TO TREAT CANCER |
| WO2018187294A1 (en) * | 2017-04-03 | 2018-10-11 | Asana Biosciences, Llc | Pyrimido-pyridazinone compound combinations, methods, kits and formulations thereof |
| KR20190140011A (en) | 2017-04-28 | 2019-12-18 | 아사나 바이오사이언시스 엘엘씨 | Formulations, methods, kits, and dosage forms for treating atopic dermatitis and improving the stability of active pharmaceutical ingredients |
| WO2022143628A1 (en) * | 2020-12-29 | 2022-07-07 | 上海岸阔医药科技有限公司 | Method for preventing or treating disease or condition associated with antitumor agent |
| KR20240151808A (en) * | 2022-02-23 | 2024-10-18 | 테바 파마슈티컬스 인터내셔널 게엠베하 | Solid state form of gusacitinib |
-
2023
- 2023-07-27 WO PCT/CN2023/109559 patent/WO2025020171A1/en active Pending
-
2024
- 2024-07-26 IL IL326152A patent/IL326152A/en unknown
- 2024-07-26 AU AU2024301493A patent/AU2024301493A1/en active Pending
- 2024-07-26 WO PCT/US2024/039745 patent/WO2025024764A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2024301493A1 (en) | 2026-03-12 |
| WO2025024764A1 (en) | 2025-01-30 |
| WO2025020171A1 (en) | 2025-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA215228S (en) | Set of earbuds | |
| EP4165031A4 (en) | Solid state forms of cyantraniliprole | |
| GB202103774D0 (en) | Detectiion of Ransomware | |
| GB202411655D0 (en) | Application of circHIF1a | |
| GB202011709D0 (en) | Solid dispersion of opicapone | |
| KR102423280B9 (en) | Sot-mram area-optimized design of sot-mram | |
| IL304159A (en) | Composition of bl-8040 | |
| IL318553A (en) | Aggregation-resistant variants of tdp-43 | |
| IL321161A (en) | Solid forms of naphthyridine compounds | |
| GB2612588B (en) | Design of engineering components | |
| GB202115776D0 (en) | Design of engineering components | |
| IL326152A (en) | Solid state forms of gusacitinib | |
| IL326153A (en) | Solid state forms of gusacitinib | |
| IL319179A (en) | Solid state forms of denifanstat | |
| IL317645A (en) | Methods of making tolebrutinib | |
| TWI922473B (en) | Solid forms of pralsetinib | |
| CA3303749A1 (en) | Solid state forms of samuraciclib | |
| CA3299990A1 (en) | Solid state forms of gusacitinib | |
| CA3299931A1 (en) | Solid state forms of gusacitinib | |
| CA3297108A1 (en) | Solid state forms of sunvozertinib | |
| CA3294911A1 (en) | Solid state forms of rencofilstat | |
| CA3268966A1 (en) | Solid state forms of denifanstat | |
| CA221466S (en) | Part of earphone | |
| GB202508287D0 (en) | Co-amorphous solid forms of flavonoids | |
| GB202215264D0 (en) | Use of urolithins |